Physician profile
John T Reed
NPI 1245461474
$5,887.42
in general payments reported to CMS, 2019-2025
8 companies · $1,610 in 2025
The $1,610 reported for 2025 was more than what 97% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.41 · 2021: $13.04 · 2023: $2,689 · 2024: $1,528 · 2025: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,602 · Food and Beverage: $2,066 · Entertainment: $565 · Long Term Medical Supply Or Device Loan: $330 · Gift: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,602.03 |
| Food and Beverage | $2,065.91 |
| Entertainment | $564.53 |
| Long Term Medical Supply Or Device Loan | $330.00 |
| Gift | $264.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,701.15 | 2019-2025 | Primescan Connect, Cerec |
| Patterson Companies, INC. | $2,349.96 | 2023-2025 | |
| 3shape INC | $330.00 | 2023 | Trios 3 |
| A-Dec, INC. | $264.50 | 2024 | |
| Solventum Corporation | $174.53 | 2024 | 3m Scotchbond, 3m Espe Filtek Supreme Ultra Universal Restorative, Filtek |
| Genentech USA, INC. | $25.62 | 2023 | Vabysmo |
| Nobel Biocare USA | $24.73 | 2019-2021 | |
| 3m Company | $16.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.